Anuncio
Anuncio

PMCB

PMCB logo

PharmaCyte Biotech, Inc. Common Stock

0.77
USD
Patrocinado
+0.05
+7.01%
22 jun, 15:59 UTC -4
Cerrado
exchange

Post-mercado

0.77

0.00
-0.01%

Panorámica financiera de PharmaCyte Biotech, Inc. Common Stock

Cap. de Mercado
8.24M
Beta
0.41
Beneficios Por Acción (BPA)
-1.12
Ratio Precio/Valor (P/V) Contable
0.19
Margen de explotación
--
Ratio de Endeudamiento total (D/C)
0.00%
Ratio PER
--
Rentabilidad sobre recursos propios (ROE)
2.13%
Ratio de liquidez
12.33%
Flujo de caja libre
-3.76M
Perfil de PMCB

Gráfico de Beneficios

Beneficios de PMCB

Valores en tendencia

Micron Technology, Inc. logo
Micron Technology, Inc.$1211.38
+6.82%
Space Exploration Technologies Corp. Class A Common Stock logo
Space Exploration Technologies Corp. Class A Common Stock$154.60
-16.43%
Nvidia Corp logo
Nvidia Corp$208.65
-0.97%
Sandisk Corporation Common Stock logo
Sandisk Corporation Common Stock$2273.73
+4.07%
Tesla, Inc. Common Stock logo
Tesla, Inc. Common Stock$405.05
+1.14%
Alphabet Inc. Class A Common Stock logo
Alphabet Inc. Class A Common Stock$349.68
-4.99%
Intel Corp logo
Intel Corp$140.94
+5.19%
Anuncio